Benzinga··Vandana SinghBristol Myers Wins FDA Approval for Opdivo Combo in Untreated Hodgkin Lymphoma
Bristol Myers wins FDA approval for Opdivo plus chemotherapy in untreated Hodgkin lymphoma. Stock declined 1.33% despite clinical success in Study CA209-8UT.
BMYCELGrFDA approvalclinical trial